Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5895 | 1562 | 42.9 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
10 | 3 | IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL | 134299 |
1321 | 2 | INTERLEUKIN 12//CD23//INTERLEUKIN 4 | 8446 |
5895 | 1 | MOL TUMOR BIOL//CELLULAR GENE THER IES//INTERLEUKIN 13 | 1562 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MOL TUMOR BIOL | address | 680010 | 5% | 48% | 72 |
2 | CELLULAR GENE THER IES | address | 588363 | 6% | 31% | 98 |
3 | INTERLEUKIN 13 | authKW | 561969 | 7% | 25% | 117 |
4 | IL 13 RECEPTOR | authKW | 344806 | 1% | 84% | 21 |
5 | INTERLEUKIN 13 RECEPTOR | authKW | 339946 | 1% | 87% | 20 |
6 | IL 13 | authKW | 335423 | 7% | 16% | 109 |
7 | INTERLEUKIN 4 | authKW | 275806 | 10% | 9% | 162 |
8 | IL 13R ALPHA 2 | authKW | 252208 | 1% | 65% | 20 |
9 | TUMOR VACCINES BIOTECHNOL BRANCH | address | 249970 | 2% | 47% | 27 |
10 | BIOL EVALUAT NIH | address | 195472 | 1% | 100% | 10 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 12066 | 42% | 0% | 661 |
2 | Oncology | 1404 | 17% | 0% | 268 |
3 | Cell Biology | 1385 | 17% | 0% | 262 |
4 | Biochemistry & Molecular Biology | 1037 | 25% | 0% | 385 |
5 | Allergy | 955 | 4% | 0% | 60 |
6 | Hematology | 781 | 8% | 0% | 118 |
7 | Medicine, Research & Experimental | 601 | 8% | 0% | 131 |
8 | Respiratory System | 125 | 3% | 0% | 46 |
9 | Biophysics | 119 | 4% | 0% | 67 |
10 | Pathology | 41 | 2% | 0% | 34 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL TUMOR BIOL | 680010 | 5% | 48% | 72 |
2 | CELLULAR GENE THER IES | 588363 | 6% | 31% | 98 |
3 | TUMOR VACCINES BIOTECHNOL BRANCH | 249970 | 2% | 47% | 27 |
4 | BIOL EVALUAT NIH | 195472 | 1% | 100% | 10 |
5 | SECT NEUROSURG H110 | 136830 | 0% | 100% | 7 |
6 | BIOL EVALUAT FOOD DRUG ADM | 63967 | 0% | 55% | 6 |
7 | PHARMAFOR PH R LSC NP | 58642 | 0% | 100% | 3 |
8 | BIOL EVALUAT | 57409 | 6% | 3% | 91 |
9 | INTERFERONS IMMUNOMODULATORS | 43980 | 0% | 75% | 3 |
10 | BIOPHYS SCI MED PHYS DOCTORAL PROGRAM | 39094 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF IMMUNOLOGY | 8769 | 10% | 0% | 156 |
2 | CYTOKINE | 6677 | 2% | 1% | 39 |
3 | EUROPEAN CYTOKINE NETWORK | 5713 | 1% | 2% | 17 |
4 | INTERNATIONAL IMMUNOLOGY | 2321 | 1% | 1% | 22 |
5 | CELLULAR IMMUNOLOGY | 1783 | 2% | 0% | 27 |
6 | JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 1726 | 2% | 0% | 31 |
7 | IMMUNOLOGY | 1705 | 2% | 0% | 28 |
8 | LYMPHOKINE RESEARCH | 1675 | 0% | 2% | 5 |
9 | AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY | 1512 | 1% | 0% | 20 |
10 | EUROPEAN JOURNAL OF IMMUNOLOGY | 1381 | 2% | 0% | 31 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INTERLEUKIN 13 | 561969 | 7% | 25% | 117 | Search INTERLEUKIN+13 | Search INTERLEUKIN+13 |
2 | IL 13 RECEPTOR | 344806 | 1% | 84% | 21 | Search IL+13+RECEPTOR | Search IL+13+RECEPTOR |
3 | INTERLEUKIN 13 RECEPTOR | 339946 | 1% | 87% | 20 | Search INTERLEUKIN+13+RECEPTOR | Search INTERLEUKIN+13+RECEPTOR |
4 | IL 13 | 335423 | 7% | 16% | 109 | Search IL+13 | Search IL+13 |
5 | INTERLEUKIN 4 | 275806 | 10% | 9% | 162 | Search INTERLEUKIN+4 | Search INTERLEUKIN+4 |
6 | IL 13R ALPHA 2 | 252208 | 1% | 65% | 20 | Search IL+13R+ALPHA+2 | Search IL+13R+ALPHA+2 |
7 | INTERLEUKIN 4 RECEPTOR | 161540 | 1% | 36% | 23 | Search INTERLEUKIN+4+RECEPTOR | Search INTERLEUKIN+4+RECEPTOR |
8 | IL 4 RECEPTOR | 141177 | 1% | 33% | 22 | Search IL+4+RECEPTOR | Search IL+4+RECEPTOR |
9 | IL 4 | 137954 | 8% | 6% | 124 | Search IL+4 | Search IL+4 |
10 | STAT6 | 124505 | 3% | 14% | 46 | Search STAT6 | Search STAT6 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SUZUKI, A , LELAND, P , JOSHI, BH , PURI, RK , (2015) TARGETING OF IL-4 AND IL-13 RECEPTORS FOR CANCER THERAPY.CYTOKINE. VOL. 75. ISSUE 1. P. 79 -88 | 87 | 63% | 11 |
2 | JOSHI, BH , HOGABOAM, C , DOVER, P , HUSAIN, SR , PURI, RK , (2006) ROLE OF INTERLEUKIN-13 IN CANCER, PULMONARY FIBROSIS, AND OTHER T(H)2-TYPE DISEASES.INTERLEUKINS. VOL. 74. ISSUE . P. 479-504 | 79 | 76% | 20 |
3 | UL-HAQ, Z , NAZ, S , MESAIK, MA , (2016) INTERLEUKIN-4 RECEPTOR SIGNALING AND ITS BINDING MECHANISM: A THERAPEUTIC INSIGHT FROM INHIBITORS TOOL BOX.CYTOKINE & GROWTH FACTOR REVIEWS. VOL. 32. ISSUE . P. 3 -15 | 87 | 40% | 1 |
4 | KAWAKAMI, K , (2005) CANCER GENE THERAPY UTILIZING INTERLEUKIN-13 RECEPTOR ALPHA 2 CHAIN.CURRENT GENE THERAPY. VOL. 5. ISSUE 2. P. 213-223 | 69 | 64% | 7 |
5 | KASAIAN, MT , MILLER, DK , (2008) IL-13 AS A THERAPEUTIC TARGET FOR RESPIRATORY DISEASE.BIOCHEMICAL PHARMACOLOGY. VOL. 76. ISSUE 2. P. 147-155 | 57 | 61% | 57 |
6 | MURATA, T , OBIRI, NI , PURI, RK , (1998) STRUCTURE OF AND SIGNAL TRANSDUCTION THROUGH INTERLEUKIN-4 AND INTERLEUKIN-13 RECEPTORS (REVIEW).INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. VOL. 1. ISSUE 3. P. 551 -557 | 63 | 72% | 71 |
7 | TABATA, Y , HERSHEY, GKK , (2007) IL-13 RECEPTOR ISOFORMS: BREAKING THROUGH THE COMPLEXITY.CURRENT ALLERGY AND ASTHMA REPORTS. VOL. 7. ISSUE 5. P. 338-345 | 44 | 80% | 30 |
8 | HERSHEY, GKK , (2003) IL-13 RECEPTORS AND SIGNALING PATHWAYS: AN EVOLVING WEB.JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. VOL. 111. ISSUE 4. P. 677-690 | 66 | 44% | 275 |
9 | KAWAKAMI, K , KIOI, M , LIU, Q , KAWAKAMI, M , PURI, RK , (2005) EVIDENCE THAT IL-13R ALPHA-2 CHAIN IN HUMAN GLIOMA CELLS IS RESPONSIBLE FOR THE ANTITUMOR ACTIVITY MEDIATED BY RECEPTOR-DIRECTED CYTOTOXIN THERAPY.JOURNAL OF IMMUNOTHERAPY. VOL. 28. ISSUE 3. P. 193-202 | 40 | 91% | 25 |
10 | PURI, S , PURI, S , MAHAPATRA, AK , HUSSAIN, E , SARKAR, C , SINHA, S , JOSHI, BH , (2009) A REVIEW OF STUDIES ON TARGETING INTERLEUKIN 4 RECEPTOR FOR CENTRAL NERVOUS SYSTEM MALIGNANCY.CURRENT MOLECULAR MEDICINE. VOL. 9. ISSUE 6. P. 732-739 | 60 | 54% | 11 |
Classes with closest relation at Level 1 |